TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $3,572,000 | -77.9% | 7,438 | -38.4% | 0.00% | – |
Q1 2019 | $16,168,000 | +404.1% | 12,066 | +325.2% | 0.00% | – |
Q4 2018 | $3,207,000 | -37.5% | 2,838 | +52.7% | 0.00% | – |
Q3 2018 | $5,131,000 | -22.7% | 1,859 | 0.0% | 0.00% | – |
Q2 2018 | $6,637,000 | -81.1% | 1,859 | -83.7% | 0.00% | – |
Q1 2018 | $35,084,000 | -49.3% | 11,428 | +4.0% | 0.00% | – |
Q4 2017 | $69,231,000 | +189.4% | 10,989 | +214.2% | 0.00% | – |
Q3 2017 | $23,926,000 | -10.4% | 3,498 | -6.6% | 0.00% | – |
Q2 2017 | $26,716,000 | +3130.5% | 3,747 | +4063.3% | 0.00% | – |
Q1 2017 | $827,000 | -51.5% | 90 | -78.7% | 0.00% | – |
Q4 2016 | $1,705,000 | -81.9% | 423 | -82.8% | 0.00% | – |
Q3 2016 | $9,399,000 | +53.8% | 2,454 | +72.7% | 0.00% | – |
Q2 2016 | $6,110,000 | -91.5% | 1,421 | -80.2% | 0.00% | – |
Q4 2015 | $71,956,000 | +27.6% | 7,174 | -5.1% | 0.00% | – |
Q3 2015 | $56,390,000 | -61.0% | 7,559 | +148.0% | 0.00% | – |
Q2 2015 | $144,597,000 | +537.6% | 3,048 | +392.4% | 0.00% | – |
Q1 2015 | $22,680,000 | -13.9% | 619 | -53.1% | 0.00% | – |
Q3 2014 | $26,354,000 | +734.8% | 1,321 | +464.5% | 0.00% | – |
Q2 2014 | $3,157,000 | +57.8% | 234 | +58.1% | 0.00% | – |
Q4 2013 | $2,001,000 | – | 148 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |